Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

The nocebo effect: a reason for patients' non-adherence to generic substitution?

Weissenfeld J, Stock S, Lüngen M, Gerber A.

Pharmazie. 2010 Jul;65(7):451-6. Review.

PMID:
20662309
[PubMed - indexed for MEDLINE]
2.

Substitution of theophylline slow-release formulations according to the rebate contracts in the German statutory health insurance.

Weissenfeld J, Lüngen M, Stock S, Drabik A, Gerber A.

Arzneimittelforschung. 2009;59(9):476-81. doi: 10.1055/s-0031-1296428.

PMID:
19856796
[PubMed - indexed for MEDLINE]
3.

Why medication in involuntary treatment may be less effective: the placebo/nocebo effect.

Meynen G, Swaab DF.

Med Hypotheses. 2011 Dec;77(6):993-5. doi: 10.1016/j.mehy.2011.08.029. Epub 2011 Sep 9.

PMID:
21907499
[PubMed - indexed for MEDLINE]
4.

Generic substitution of antihypertensive drugs: does it affect adherence?

Van Wijk BL, Klungel OH, Heerdink ER, de Boer A.

Ann Pharmacother. 2006 Jan;40(1):15-20. Epub 2005 Nov 22.

PMID:
16303985
[PubMed - indexed for MEDLINE]
5.

A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.

Papadopoulos D, Mitsikostas DD.

J Neurol. 2012 Mar;259(3):436-47. doi: 10.1007/s00415-011-6197-4. Epub 2011 Aug 3.

PMID:
21811804
[PubMed - indexed for MEDLINE]
6.

Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice.

Mitsikostas DD, Chalarakis NG, Mantonakis LI, Delicha EM, Sfikakis PP.

Eur J Neurol. 2012 May;19(5):672-80. doi: 10.1111/j.1468-1331.2011.03528.x. Epub 2011 Oct 4. Review.

PMID:
21973313
[PubMed - indexed for MEDLINE]
7.

Nocebo in headaches: implications for clinical practice and trial design.

Mitsikostas DD.

Curr Neurol Neurosci Rep. 2012 Apr;12(2):132-7. doi: 10.1007/s11910-011-0245-4. Review.

PMID:
22193945
[PubMed - indexed for MEDLINE]
8.

Bioequivalence and other unresolved issues in generic drug substitution.

Meredith P.

Clin Ther. 2003 Nov;25(11):2875-90.

PMID:
14693311
[PubMed - indexed for MEDLINE]
9.

[Nocebo effect: the other side of placebo].

Ferreres J, Baños JE, Farré M.

Med Clin (Barc). 2004 Apr 10;122(13):511-6. Review. Spanish.

PMID:
15104949
[PubMed - indexed for MEDLINE]
10.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
11.

Nocebo phenomena in medicine: their relevance in everyday clinical practice.

Häuser W, Hansen E, Enck P.

Dtsch Arztebl Int. 2012 Jun;109(26):459-65. doi: 10.3238/arztebl.2012.0459. Epub 2012 Jun 29. Review.

PMID:
22833756
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The nocebo effect and its relevance for clinical practice.

Colloca L, Miller FG.

Psychosom Med. 2011 Sep;73(7):598-603. doi: 10.1097/PSY.0b013e3182294a50. Epub 2011 Aug 23. Review.

PMID:
21862825
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationship.

Olshansky B.

J Am Coll Cardiol. 2007 Jan 30;49(4):415-21. Epub 2007 Jan 16. Review.

PMID:
17258086
[PubMed - indexed for MEDLINE]
Free Article
14.

Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review.

Van Wijk BL, Klungel OH, Heerdink ER, de Boer A.

Ann Pharmacother. 2005 Feb;39(2):319-28. Epub 2005 Jan 4. Review.

PMID:
15632223
[PubMed - indexed for MEDLINE]
15.

Generic substitution: additional challenge for adherence in hypertensive patients?

Håkonsen H, Eilertsen M, Borge H, Toverud EL.

Curr Med Res Opin. 2009 Oct;25(10):2515-21. doi: 10.1185/03007990903192223.

PMID:
19708764
[PubMed - indexed for MEDLINE]
16.

A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.

Frogel MP, Stewart DL, Hoopes M, Fernandes AW, Mahadevia PJ.

J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. Review.

PMID:
20131495
[PubMed - indexed for MEDLINE]
Free Article
17.

The measurement and monitoring of surgical adverse events.

Bruce J, Russell EM, Mollison J, Krukowski ZH.

Health Technol Assess. 2001;5(22):1-194. Review.

PMID:
11532239
[PubMed - indexed for MEDLINE]
Free Article
18.

Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study.

Steinberg SC, Faris RJ, Chang CF, Chan A, Tankersley MA.

Clin Drug Investig. 2010;30(2):89-100. doi: 10.2165/11533330-000000000-00000.

PMID:
20067327
[PubMed - indexed for MEDLINE]
19.

Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study.

Mansur N, Weiss A, Hoffman A, Gruenewald T, Beloosesky Y.

Drugs Aging. 2008;25(10):861-70.

PMID:
18808210
[PubMed - indexed for MEDLINE]
20.

Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD prevention.

Johnston A.

Curr Med Res Opin. 2010 Apr;26(4):871-8. doi: 10.1185/03007990903578462.

PMID:
20144139
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk